Short answer
MapLight Therapeutics, Inc. (MPLT) filed an 8-K current report with the SEC on June 24, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 86.56% shareholder participation, with 36,883,750 of 42,610,079 shares represented.
MapLight Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 86.56% shareholder participation, with 36,883,750 of 42,610,079 shares represented
- Martin Babler, Troy Cox, and George Pavlov elected as directors through the 2029 annual meeting
- Troy Cox received strongest support, with 34,979,012 votes for and 20,919 withheld
- RSM US LLP ratified as fiscal 2026 independent auditor by 36,859,217 votes
- Auditor ratification faced minimal opposition, with 22,332 against and 2,201 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MapLight Therapeutics, Inc. 8-K filings
Get the next MPLT 8-K as it lands
Follow MPLT for push alerts, or ask the research agent what this filing means.